+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390



Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390



European Journal of Pharmacology 109(1): 127-128




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 041321635

Download citation: RISBibTeXText

PMID: 2859993

DOI: 10.1016/0014-2999(85)90549-7


Related references

Chronic treatment with SCH 23390, a selective dopamine D-1 receptor antagonist, decreases dopamine metabolism in rat caudate nucleus. European Journal of Pharmacology 155(3): 313-316, 1988

Effects of chronic sch 23390 treatment on the biochemical and behavioral properties of d 1 and d 2 dopamine receptors potentiated behavioral responses to a d 2 dopamine agonist after selective d 1 dopamine receptor upregulation. Journal of Pharmacology & Experimental Therapeutics 238(3): 846-854, 1986

Effects of chronic methamphetamine treatment on the binding parameters of [3H]SCH 23390, a selective D1-dopamine receptor ligand, in the rat brain. Neuroscience Letters 120(1): 109-112, 1990

Spontaneous activity of A9 and A10 dopamine neurons after acute and chronic administration of the selective dopamine D-1 receptor antagonist SCH 23390. European Journal of Pharmacology 155(1-2): 175-180, 1988

Chronic treatment with SCH-23390, a selective dopamine D1 receptor blocker decreases preprotachykinin-A mRNA levels in nucleus tractus solitarii of the rabbit: role in respiratory control. Brain Research. Molecular Brain Research 9(3): 233-238, 1991

Chronic treatment with sch 23390 a selective dopamine d 1 receptor blocker decreases preprotachykinin a messenger rna levels in nucleus tractus solitarii of the rabbit role in respiratory control. Molecular Brain Research 9(3): 233-238, 1990

D 1 dopamine receptor changes after chronic treatment with sch 23390 and or haloperidol. Society for Neuroscience Abstracts 13(2): 1343, 1987

Selective blockade of dopamine D-1 receptor by SCH 23390 affects dopamine agonist binding to 3H-spiperone labeled D-2 receptors in rat striatum. Japanese Journal of Pharmacology 50(3): 333-345, 1989

Selective D2 dopamine receptor agonists prevent catalepsy induced by SCH 23390, a selective D1 antagonist. Life Sciences 36(19): 1857-1864, 1985

Selective blockade of dopamine d 1 receptor by sch 23390 affects dopamine agonist binding to tritiated spiperone labeled d 2 receptors in rat striatum. Japanese Journal of Pharmacology 50(3): 333-346, 1989

SCH 23390: the first selective dopamine D1-like receptor antagonist. Cns Drug Reviews 7(4): 399-414, 2001

SCH 23390--a selective dopamine D-1 receptor antagonist with putative 5-HT1 receptor agonistic activity. European Journal of Pharmacology 148(3): 389-395, 1988

3H]SCH 23390 binding sites increase after chronic blockade of D-1 dopamine receptors. European Journal of Pharmacology 118(3): 367-370, 1985

D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists. Journal of Pharmacology and Experimental Therapeutics 260(1): 409-416, 1992

Functional evidence for selective dopamine D-1 receptor blockade by SCH 23390. Neuropharmacology 23(12a): 1395-1401, 1984